SCHEMBL4923273

SCHEMBL4923273

O=C(Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)nc2)cc1)Nc1cc(C(F)(F)F)ccc1F

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 14/20 0.77
KDR P35968 3/20 0.48
PDGFRB P09619 2/20 0.48
RIPK1 Q13546 2/20 0.47
TEK Q02763 2/20 0.47
EGFR P00533 1/20 0.47
CSF1R P07333 1/20 0.47
SRC P12931 1/20 0.47
PDGFRA P16234 1/20 0.47
FLT1 P17948 1/20 0.47
CDK2 P24941 1/20 0.47
FLT4 P35916 1/20 0.47
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47
AKT3 Q9Y243 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
EPHB4 P54760 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4921622 1.00 DGAT1 (0.77) DGAT1KDRPDGFRBRIPK1TEK
SCHEMBL4921617 1.00 DGAT1 (0.77) DGAT1KDRPDGFRBRIPK1TEK
SCHEMBL4890035 0.87 DGAT1 (1.00) DGAT1KDRCA12CA1CA2
SCHEMBL4922049 0.86 DGAT1 (0.76) DGAT1KDRTEK
SCHEMBL4922046 0.86 DGAT1 (0.76) DGAT1KDRTEK
SCHEMBL4922056 0.86 DGAT1 (0.76) DGAT1KDRTEK
SCHEMBL4922075 0.85 DGAT1 (0.61) DGAT1
SCHEMBL4922067 0.85 DGAT1 (0.61) DGAT1
SCHEMBL4922079 0.85 DGAT1 (0.61) DGAT1
SCHEMBL4924477 0.84 DGAT1 (0.72) DGAT1KDRPDGFRBRIPK1TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme DGAT1, DGAT2, DLAT DGAT1 1/4885KDR 4607/4885PDGFRB 3310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.